Skip to content
Wenlo
Sign in
← Markets

Revolution Medicines, Inc.

Jack Anders (Chief Financial Officer) sells RVMD shares

4RVMDFiled Nov 13, 2026, 6:00 PM ET· Period Nov 11, 2026

AI-generated summary

Chief Financial Officer Jack Anders exercised options to acquire 35,750 shares of common stock for $1,043,371 and sold 35,750 shares of common stock for an average price of $188.10, totaling $6,724,687.85. After these transactions, Anders directly held 119,216 shares of common stock. All transactions were executed under a Rule 10b5-1 trading plan adopted on August 12, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Jack Anders · Chief Financial Officer

Rule 10b5-1 plan · adopted Aug 12, 2026

DateTransactionSharesPriceValueHeld afterOwnership
Nov 11, 2026M · exercise or conversion of a derivativeFootnotes F1+15,900$42.45$674,955.00135,116Direct
Nov 11, 2026M · exercise or conversion of a derivativeFootnotes F1+19,850$18.56$368,416.00154,966Direct
Nov 11, 2026S · open-market saleFootnotes F1, F2−3,499$181.04$633,466.31151,467Direct
Nov 11, 2026S · open-market saleFootnotes F1, F3−5,776$182.09$1,051,752.42145,691Direct
Nov 11, 2026S · open-market saleFootnotes F1, F4−2,700$182.87$493,750.08142,991Direct
Nov 11, 2026S · open-market saleFootnotes F1, F5−1,900$184.02$349,646.74141,091Direct
Nov 11, 2026S · open-market saleFootnotes F1, F6−800$185.04$148,029.04140,291Direct
Nov 11, 2026S · open-market saleFootnotes F1, F7−400$186.41$74,565.52139,891Direct
Nov 11, 2026S · open-market saleFootnotes F1, F8−600$187.34$112,402.26139,291Direct
Nov 11, 2026S · open-market saleFootnotes F1−200$189.17$37,834.00139,091Direct
Nov 11, 2026S · open-market saleFootnotes F1, F9−500$190.99$95,497.00138,591Direct
Nov 11, 2026S · open-market saleFootnotes F1, F10−9,486$191.94$1,820,743.79129,105Direct
Nov 11, 2026S · open-market saleFootnotes F1, F11, F12−9,889$192.84$1,907,000.69119,216Direct
Nov 11, 2026M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F13−15,900$42.45$674,955.000Direct
Nov 11, 2026M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F13−19,850$18.56$368,416.00750Direct
Footnotes
  1. F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 12, 2026.
  2. F2 The transaction was executed in multiple trades at prices ranging from $180.50 to $181.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. F3 The transaction was executed in multiple trades at prices ranging from $181.51 to $182.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. F4 The transaction was executed in multiple trades at prices ranging from $182.56 to $183.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  5. F5 The transaction was executed in multiple trades at prices ranging from $183.59 to $184.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  6. F6 The transaction was executed in multiple trades at prices ranging from $184.59 to $185.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  7. F7 The transaction was executed in multiple trades at prices ranging from $185.96 to $186.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  8. F8 The transaction was executed in multiple trades at prices ranging from $186.99 to $187.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  9. F9 The transaction was executed in multiple trades at prices ranging from $190.43 to $191.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  10. F10 The transaction was executed in multiple trades at prices ranging from $191.44 to $192.43, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  11. F11 The transaction was executed in multiple trades at prices ranging from $192.44 to $193.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  12. F12 Includes 43,650 restricted stock units.
  13. F13 Fully vested.

More RVMD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.